{
  "id": 3597,
  "text": "1586.Schilder, R.J., Blessing, J.A., Morgan, M., Mangan, C.E.& Rader, J.S.Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1586.Schilder, R.J., Blessing, J.A., Morgan, M., Mangan, C.E.& Rader, J.S.Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "吉西他滨（Gemcitabine）是一种广泛应用于多种实体肿瘤的抗代谢类化疗药物，对于宫颈鳞状细胞癌的患者，其疗效已经在多项研究中得到一定的验证。从研究数据来看，吉西他滨通常与其他药物联合使用，能够增强治疗效果。例如，与顺铂等药物的联合治疗在晚期或复发性宫颈鳞状细胞癌患者中显示了一定的客观缓解率，并改善了一些患者的生存期。同时，吉西他滨的安全性和耐受性较好，尽管仍需关注可能的骨髓抑制等副作用。根据具体患者的病情和治疗目标，应在专业医生的指导下选择个体化的治疗方案。",
  "query": "**在治疗宫颈鳞状细胞癌的患者中，如何评价吉西他滨的疗效？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **在治疗宫颈鳞状细胞癌的患者中，如何评价吉西他滨的疗效？**\n\n<reference text>: 1586.Schilder, R.J., Blessing, J.A., Morgan, M., Mangan, C.E.& Rader, J.S.Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "吉西他滨（Gemcitabine）是一种广泛应用于多种实体肿瘤的抗代谢类化疗药物，对于宫颈鳞状细胞癌的患者，其疗效已经在多项研究中得到一定的验证。从研究数据来看，吉西他滨通常与其他药物联合使用，能够增强治疗效果。例如，与顺铂等药物的联合治疗在晚期或复发性宫颈鳞状细胞癌患者中显示了一定的客观缓解率，并改善了一些患者的生存期。同时，吉西他滨的安全性和耐受性较好，尽管仍需关注可能的骨髓抑制等副作用。根据具体患者的病情和治疗目标，应在专业医生的指导下选择个体化的治疗方案。"
}